Stock market giants including Nvidia and Walmart completed stock splits in 2024. Investors like these operations because they ...
The Food and Drug Administration (FDA) has reaffirmed that Mounjaro and Zepbound are no longer in shortage following a ...
The FDA’s decision will close a lucrative market opportunity for compounding pharmacies, although the agency will give a ...
Stay updated on the latest developments in the GLP-1 drug class, including a new generic entering the market, weight loss results, FDA decisions & cost issues.
Eli Lilly's stock has been a strong winner over the past few years, powered by its portfolio of glucagon-like peptide-1 ...
When you’re on TV every week, it’s hard to hide when you’ve lost weight, especially in a short period of time. Luckily, ...
The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...